Sorafenib: tolerance in patients on chronic hemodialysis: a single-center experience

Oncology
Pablo Maroto Rey, Humberto Villavicencio

Abstract

Improved understanding of renal cell carcinomas (RCC) and recent contributions in the field of RCC biology led to the development of a novel class of drugs, i.e. multiple-kinase inhibitors, targeting growth factor receptors (e.g. sorafenib). Sorafenib has proven significant benefit in terms of progression-free survival in a phase II trial in RCC patients. A subsequent randomized phase III study (Treatment Approaches in Renal Cancer Global Evaluation Trial) confirmed the significantly prolonged progression-free survival and improvement in the quality of life compared to patients receiving placebo. In the USA and Europe, sorafenib has been approved for the treatment of advanced RCC. Two RCC patients on chronic hemodialysis were treated with sorafenib. Both patients responded to sorafenib treatment. Apart from high blood pressure, a major adverse effect of sorafenib treatment, treatment was well tolerated, in agreement with previous results. The results of our study confirm the beneficial effect of sorafenib in the treatment of RCC in our 2 patients on dialysis.

Citations

Feb 13, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F J AfonsoL Antón-Aparicio
Jan 13, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M ReckovaJ Beniak
Feb 24, 2016·Clinical Genitourinary Cancer·Alessandro LeonettiSebastiano Buti
Jul 15, 2015·International Journal of Clinical Oncology·Kenji OmaeKazunari Tanabe
Mar 23, 2011·Critical Reviews in Oncology/hematology·José Ángel ArranzJosé Pablo Maroto
May 4, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Takamichi IshiiShinji Uemoto
Mar 19, 2015·Japanese Journal of Clinical Oncology·Yuichiro KitaiMotoko Yanagita
Aug 27, 2013·Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology·Shuichi KatoMasahiro Yanase
Jul 1, 2010·Expert Opinion on Pharmacotherapy·Renuka IyerYasmin Thanavala

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacology and Therapeutics
R A HilgerM E Scheulen
The New England Journal of Medicine
Bernard EscudierTARGET Study Group
The New England Journal of Medicine
Robert J MotzerRobert A Figlin
© 2022 Meta ULC. All rights reserved